Cyril Empig

1.8k citations
15 papers · 1.4k · 1 hit paper · h-index 12

Impact in

  • Virology top 2%
    • Poxvirus research and outbreaks
  • Immunology top 5%
    • Phagocytosis and Immune Regulation
    • Immune cells in cancer

Papers in

Cyril Empig

14 papers receiving 1.4k citations

Hit Papers

Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer 2016 · 532 citations
5320+3+6Years since publication100200300400500

Peers

Cyril Empig
Comparison fields: 5 of 96
  • Virology 267
  • Immunology 589
  • Infectious Diseases 347
  • Epidemiology 302
  • Molecular Biology 560
Replace Paul A Santini with:
Paul A Santini United States
Christian Körner Germany
Kosuke Miyauchi Japan
Guy T. Layton United Kingdom
Hua-Poo Su United States
John Hural United States
Paola Del Porto Italy
George J. Cianciolo United States
George J. Leslie United States
Jesper Melchjorsen Denmark
Cyril Empig relative to Paul A Santini United States Paul A Santini's profile →
Citations per field
00.5×
Paul A Santini · 1×
Citations per year

Countries citing papers authored by Cyril Empig

Since Specialization
Citations

This map shows the geographic impact of Cyril Empig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cyril Empig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cyril Empig more than expected).

Fields of papers citing papers by Cyril Empig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cyril Empig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cyril Empig. The network helps show where Cyril Empig may publish in the future.

Co-authors

The 25 scholars most cited alongside Cyril Empig, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Cyril Empig Line = papers co-authored together Cyril Empig links everyone, so they are left out of the graph.

All Works

15 of 15 papers shown
#Work
1
Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer
Hit paper breakdown →
2016532
2 2001171
3 2006129
4 2002116
5 2017105
6 1995102
7 201174
8 200546
9 201430
10 201227
11 201426
12 201515
13 201211
14 20124
15 20210

About Cyril Empig

Cyril Empig is a scholar working on Infectious Diseases, Epidemiology, Virology, Immunology and Molecular Biology, having authored 15 papers that have together received 1.4k indexed citations. Recurring topics across this work include Viral Infections and Outbreaks Research (6 papers), Hepatitis B Virus Studies (4 papers), Bacillus and Francisella bacterial research (3 papers), Poxvirus research and outbreaks (3 papers), HIV Research and Treatment (2 papers), Phagocytosis and Immune Regulation (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Viral Infections and Vectors (2 papers). The work is most often cited by research in Virology (267 citations), Immunology (589 citations), Infectious Diseases (347 citations), Epidemiology (302 citations) and Molecular Biology (560 citations). Cyril Empig has collaborated with scholars based in United States, United Kingdom and Slovakia. Frequent co-authors include Mark A. Goldsmith, Raymond B. Birge, Bruce Freimark, Sushil Kumar, Marc Gurwith, Julie Kenner, Martin Herrmann, J. Hutchins, Xin Huang and Rolf A. Brekken. Their work appears in journals such as Vaccine, PLoS ONE, Molecular Cancer Research, Clinical Cancer Research and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact